Delaram Ghanooni to HIV Infections
This is a "connection" page, showing publications Delaram Ghanooni has written about HIV Infections.
Connection Strength
1.511
-
Ghanooni D, Carrico AW, Flentje A, Moreno PI, Harkness A, Dilworth S, Pahwa S, Pallikkuth S, Regan S, Aouizerat BE, Duncan DT. Neighborhood-level adversity and inflammation among sexual minority men living with HIV. Health Psychol. 2025 Mar; 44(3):188-196.
Score: 0.337
-
Ghanooni D, Flentje A, Hirshfield S, Horvath KJ, Moreno PI, Harkness A, Ross EJ, Dilworth SE, Pahwa S, Pallikkuth S, Carrico AW. Structural Determinants of Health and Markers of Immune Activation and Systemic Inflammation in Sexual Minority Men With and Without HIV. J Urban Health. 2024 Aug; 101(4):867-877.
Score: 0.320
-
Ghanooni D, Carrico AW, Williams R, Glynn TR, Moskowitz JT, Pahwa S, Pallikkuth S, Roach ME, Dilworth S, Aouizerat BE, Flentje A. Sexual Minority Stress and Cellular Aging in Methamphetamine-Using Sexual Minority Men With Treated HIV. Psychosom Med. 2022 10 01; 84(8):949-956.
Score: 0.282
-
Chavez JV, Davis Ewart L, Ilyas O, Ghanooni D, Diaz JE, Atkins L, Ramos R, Hernandez A, Stewart A, Horovath KJ, Hirshfield S, Carrico AW. 'I was like, this is gonna hurt': Implementing self-sampling of dried blood spots to measure HIV viral load. PLoS One. 2025; 20(5):e0322740.
Score: 0.085
-
Davis Ewart L, Larson ME, Ghanooni D, Verhagen R, Manuel J, McCollister K, Fardone E, DeVries B, Dilworth S, Blackstock M, Doblecki-Lewis S, Nahum-Shani I, Grov C, Carrico AW. Getting to yes: Pilot sequential multiple assignment randomized trial of motivational enhancement interventions targeting preexposure prophylaxis use in sexual minority men who use stimulants. Health Psychol. 2025 Mar; 44(3):310-320.
Score: 0.084
-
Davis-Ewart L, Atkins L, Ghanooni D, Diaz JE, Chuku CC, Balise R, DeVries BA, Miller-Perusse M, Ackley Iii D, Moskowitz JT, McCollister K, Fardone E, Hirshfield S, Horvath KJ, Carrico AW. Supporting treatment adherence for resilience and thriving (START): protocol for a mHealth randomized controlled trial. BMC Public Health. 2024 08 29; 24(1):2350.
Score: 0.081
-
Diaz JE, Ghanooni D, Atkins L, Sam SS, Kantor R, Miller-Perusse M, Chuku CC, Valentin O, Balise RR, Davis-Ewart L, Tisler A, Horvath KJ, Carrico AW, Hirshfield S. Challenges and Opportunities with at-Home Blood Collection for HIV-1 Viral Load Monitoring among Sexual Minoritized Men who use Stimulants. AIDS Behav. 2024 Nov; 28(11):3809-3818.
Score: 0.081
-
Carrico AW, Cherenack EM, Flentje A, Moskowitz JT, Asam K, Ghanooni D, Chavez JV, Neilands TB, Dilworth SE, Rubin LH, Gouse H, Fuchs D, Paul RH, Aouizerat BE. A positive affect intervention alters leukocyte DNA methylation in sexual minority men with HIV who use methamphetamine. Brain Behav Immun. 2024 Aug; 120:151-158.
Score: 0.080
-
Carrico AW, Cherenack EM, Rubin LH, McIntosh R, Ghanooni D, Chavez JV, Klatt NR, Paul RH. Through the Looking-Glass: Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era. Psychosom Med. 2022 10 01; 84(8):984-994.
Score: 0.071
-
Viamonte M, Ghanooni D, Reynolds JM, Grov C, Carrico AW. Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men. Curr HIV/AIDS Rep. 2022 08; 19(4):235-250.
Score: 0.070
-
Ross EJ, Jimenez DE, Ghanooni D, Mendez A, Hirshfield S, Horvath KJ, DeVries B, Dilworth SE, Carrico AW, Martinez CA. Loneliness, Methamphetamine Use, and Cardiovascular Risk Factors Among Sexual Minority Men in the COVID-19 Era. Int J Behav Med. 2025 Apr; 32(2):267-275.
Score: 0.020